These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 7630745
1. [Potential and limitation of myocardial perfusion scintigraphy for detection of viability]. Knapp WH. Nuklearmedizin; 1995 Jun; 34(3):118-26. PubMed ID: 7630745 [Abstract] [Full Text] [Related]
7. [Thallium scintigraphy for determining myocardial vitality. Evaluation of the "stunned and hibernating myocardium"]. Nienaber CA, Carnarius H. Herz; 1994 Feb; 19(1):7-18. PubMed ID: 8150416 [Abstract] [Full Text] [Related]
9. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging. Schröter G, Schneider-Eicke J, Schwaiger M. Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413 [Abstract] [Full Text] [Related]
10. Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation. Ferrari R, Ceconi C, Curello S, Benigno M, La Canna G, Visioli O. J Cardiovasc Pharmacol; 1996 Feb; 28 Suppl 1():S18-26. PubMed ID: 8891867 [Abstract] [Full Text] [Related]
11. Myocardial thallium-201 scintigraphy for assessment of viability in patients with severe left ventricular dysfunction. Beller GA, Ragosta M, Watson DD, Gimple LW. Am J Cardiol; 1992 Nov 05; 70(14):18E-22E. PubMed ID: 1442567 [Abstract] [Full Text] [Related]
12. Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability. Go RT, MacIntyre WJ, Saha GB, Cook SA, Neumann DR, Chen EQ, Underwood DA, Kaczur T. Radiology; 1995 Jan 05; 194(1):151-5. PubMed ID: 7997543 [Abstract] [Full Text] [Related]
13. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging? Bax JJ, Wijns W. J Nucl Med; 1999 Nov 05; 40(11):1893-5. PubMed ID: 10565786 [No Abstract] [Full Text] [Related]
14. Positron emission tomography for the assessment of myocardial viability: a synopsis of methods and indications. Lucignani G, Landoni C, Paolini G, Messa MC, Gilardi MC, Rossetti C, Fazio F. Rays; 1999 Nov 05; 24(1):81-95. PubMed ID: 10358386 [Abstract] [Full Text] [Related]
15. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET. Tamaki N, Ohtani H, Yonekura Y, Shindo M, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J. J Cardiol; 1992 Nov 05; 22(2-3):283-93. PubMed ID: 1339787 [Abstract] [Full Text] [Related]
16. Comparison of thallium scintigraphy and positron emission tomography. Niemeyer MG, Kuijper AF, Meeder JG, Cramer MJ, Cleophas AJ, van der Wall EE. Angiology; 1997 Oct 05; 48(10):843-53. PubMed ID: 9342963 [Abstract] [Full Text] [Related]
17. Adaptation of nonrevascularized human hibernating and chronically stunned myocardium to long-term chronic myocardial ischemia. Wiggers H, Nielsen SS, Holdgaard P, Flø C, Nørrelund H, Halbirk M, Nielsen TT, Egeblad H, Rehling M, Bøtker HE. Am J Cardiol; 2006 Dec 15; 98(12):1574-80. PubMed ID: 17145213 [Abstract] [Full Text] [Related]
18. Myocardial SPECT in the study of ischemic heart disease detection of hibernating myocardium and evaluation of cost/benefit ratio. Giordano A, Calcagni ML, Verrillo A, Maccafeo S. Rays; 1999 Dec 15; 24(1):73-80. PubMed ID: 10358385 [Abstract] [Full Text] [Related]